Full name
"LEK PHARMA" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
41 - Construction work related to the construction of residential and non-residential buildings
42 - Works related to the construction of civil engineering and water engineering objects
43 - Specialized construction works
46.45.Z - Wholesale trade of perfumes and cosmetics
47.74.Z - Retail sale of medical and orthopedic products
64.92.Z - Other forms of credit granting
68 - Real estate activities
70.22.Z - Head office activities and management consultancy
77 - Rental and leasing
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | -28,1 | 16 | 0 | -100 |
EBITDA | -11,4 | 29 | 0 | -100 |
Short time liabilities | 270,8 | 197,2 | 197,1 | -0 |
Equity capital | 39,5 | 55,5 | 55,5 | 0 |
Operating profit (EBIT) | -11,4 | 29 | 0 | -100 |
Assets | 347 | 252,7 | 252,7 | 0 |
Net profit (loss) | -28,1 | 16 | 0 | -100 |
Cash | 10,1 | 0 | 0 | 0 |
Net income from sale | 0 | 43,5 | 0 | -100 |
Liabilities and provisions for liabilities | 307,5 | 197,2 | 197,2 | 0 |
Working assets | 141,5 | 122,3 | 122,3 | 0 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | -71,2 | 28,8 | 0 | -28,8 |
Equity capital to total assets | 11,4 | 22 | 22 | 0 |
Gross profit margin | 36,8 | |||
EBITDA Margin | 66,6 | |||
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 1654 | 2 147 483 648 | 2 147 481 994 |
Current financial liquidity indicator | 0.5225538611412048 | 0.6201026439666748 | 0.6203166246414185 | 0 |
Net dept to EBITDA | -24.985212326049805 | 6.492714881896973 | 31,5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane